29
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lessons learned from HIV can inform our approach to COVID‐19 stigma

      article-commentary
      1 ,
      Journal of the International AIDS Society
      John Wiley and Sons Inc.
      COVID‐19, stigma, HIV, gender, community, history

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Stigma targeting people associated with COVID‐19, particularly persons of Asian descent, has been reported in media spanning diverse global contexts [1]. The United Nations described that “fear, rumours and stigma” are key challenges accompanying COVID‐19 [2]. The convergence of its framing as a “foreign virus” and an “infodemic” ignited this fear and stigma [2, 3]. This is not a new phenomenon. Blaming epidemics on a foreign “other” is a recurring historic narrative [4, 5]. We can leverage our four decades of HIV research to understand and address COVID‐19 stigma. First, HIV reflects the health, moral and racial dimensions of stigma theorized by Goffman [6] and aligned with historical patterns of disease attribution [4, 5]. Stigma is produced in social processes of labelling that differentiate persons characterized as “normal” from the “abnormal” other. Archetypes of the other include racial and religious minorities as well as people labelled as physically unhealthy or “immoral” [6]. In the early 1980s the HIV epidemic – initially coined Gay‐Related Immune Deficiency (GRID) – was conceptualized as a plague that impacted “at risk” populations in the US known as the “4‐H’s” (haemophiliacs, heroin users, homosexuals, Haitians) [7, 8]. This framing blamed racial (Haitian) and “immoral” (e.g. gay men) others and positioned a foreign location (Haiti) as the origin of HIV in the US. The World Health Organization deliberately named COVID‐19 to avoid conflation with a location of origin [3], yet referrals to it as the “Chinese” and “Wuhan” virus persist [9]. The arrests of people for breaching COVID‐19 public health measures [10] – and subsequent labelling as “intentional murderers” [11] and “super spreaders” [12] – signal the creation of the “immoral” other. These arrests contradict UNAIDS recommendations to avoid criminal repercussions for breaching COVID‐19 public health restrictions [13]. Similar to HIV, we need to address several facets of COVID‐19 stigma to effectively reduce it. These include exposing and eliminating racism and xenophobia and recognizing the social processes of othering already experienced by persons blamed for COVID‐19 (including stigma and socio‐economic exclusion experienced by immigrants [14]). Second, HIV has taught us about the complexity of stigma. We are moving away from siloed stigma research on individual health conditions (e.g. HIV, mental health), social identities (e.g. race, sexual orientation) and practices (e.g., sex work, drug use) [15]. Instead, stigma is understood as intersectional, social ecological, and produced by drivers (e.g., misinformation) and facilitators (e.g., inequitable social norms) [15, 16, 17, 18]. Intersecting stigma – such as racism and poverty – interact with HIV‐related stigma to harm health engagement and outcomes [16, 17] and may present analogous barriers to COVID‐19 testing and treatment [14]. Stigma also operates across multiple, interacting dimensions of life. Social ecological approaches to HIV remind us that stigma is intrapersonal (affecting our self‐perception and mental health), interpersonal (altering our relationships), social (embedded in community norms and values) and structural (reproduced institutionally in health, legal, employment and other practices) [15, 16]. Researchers can apply this lens to explore COVID‐19 stigma’s effects on mental health, intimate relationships [18], community cohesiveness, and interactions with police, employers, healthcare providers, among others. Stigma experiences are shaped by intersecting social identities. Researchers have called for a gender‐based analysis of COVID‐19 [18, 19]. We urgently need to examine the gendered nature of COVID‐19 stigma, particularly in light of HIV‐related stigma research that shows its associations with gender‐based violence [e.g. 20]. Age is another identity that may shape COVID‐19 stigma manifestations. There are complex associations between HIV‐related stigma and age, whereby older persons living with HIV may experience reduced health effects of stigma [21, 22]. This could differ from COVID‐19, where the distressing choice of rationing intensive care hospital beds and ventilators has sparked debate over choosing who should live and who should die [23, 24]. The recommended utilitarian approach favours prioritizing treatment for young, severely ill persons [24]. What implications does this scarcity of COVID‐19 medical resources have on stigma towards older persons? Understanding specific contexts of COVID‐19 stigma can inform tailored mitigation strategies. However, the great challenge remains that COVID‐19 is a moving target with continually changing dynamics. Groups impacted by stigma may change as the pandemic evolves. While Asian communities were initially blamed for COVID‐19 [1, 9], will this liability shift to other marginalized communities, such as undocumented immigrants, homeless persons, and others who experience barriers to testing and care [14]? We can also apply lessons from HIV‐related stigma reduction interventions to COVID‐19. Community‐based approaches to reducing HIV‐related stigma focus on generating solidarity and reclaiming identities [3, 13, 16, 25]. Such COVID‐19 stigma resistance tactics have already emerged, evidenced with the Twitter hashtags #IamNotaVirus, #NoSoyUnVirus and #JeNeSuisPasUnVirus. There is a rich evidence‐base of HIV‐related stigma interventions for healthcare providers that provide HIV information, share how stigma affects communities, encourage reflection on personal biases and ensure institutional support for stigma mitigation [13, 26, 27]. Other strategies include participatory learning through engaging activities such as discussions, games and role‐play [26, 27]. The contact approach involves people who have experienced the stigma being targeted (e.g. persons living with HIV, persons experiencing COVID‐19 stigma) delivering the intervention to provide a face to the pandemic that in turn can foster empathy and reduce othering [26, 27]. Moving forward we need not only focus on the stories of hardship in the midst of an epidemic [28], but to also remember the complexity and fullness of people’s lives. For instance, there are videos circulating on social media of people quarantined in Italy for COVID‐19 singing to one another from their balconies. The HIV epidemic simultaneously produced stigma and created communities among affected persons [7, 8]. Creating space for stories of COVID‐19 that reveal stigma and solidarity, of front‐line healthcare workers’ experiences, and of people living in quarantine, can reduce fear and spark empathy by helping us to see ourselves and our communities reflected in the pandemic [28]. Understanding our shared humanity and the precarity of distinguishing the “sick” and “healthy” may be a step towards fostering solidarity. Sontag [4] reminds us that we are interconnected in our vulnerability to sickness: Illness is the night‐side of life, a more onerous citizenship. Everyone who is born holds dual citizenship, in the kingdom of the well and in the kingdom of the sick. Although we all prefer to use only the good passport, sooner or later each of us is obliged, at least for a spell, to identify ourselves as citizens of that other place. (p. 3). Competing interest None. Author’s contributions CHL conceptualized and wrote the manuscript. She read and approved the final manuscript.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: not found
          • Article: not found

          Fair Allocation of Scarce Medical Resources in the Time of Covid-19

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            COVID-19: the gendered impacts of the outbreak

            Policies and public health efforts have not addressed the gendered impacts of disease outbreaks. 1 The response to coronavirus disease 2019 (COVID-19) appears no different. We are not aware of any gender analysis of the outbreak by global health institutions or governments in affected countries or in preparedness phases. Recognising the extent to which disease outbreaks affect women and men differently is a fundamental step to understanding the primary and secondary effects of a health emergency on different individuals and communities, and for creating effective, equitable policies and interventions. Although sex-disaggregated data for COVID-19 show equal numbers of cases between men and women so far, there seem to be sex differences in mortality and vulnerability to the disease. 2 Emerging evidence suggests that more men than women are dying, potentially due to sex-based immunological 3 or gendered differences, such as patterns and prevalence of smoking. 4 However, current sex-disaggregated data are incomplete, cautioning against early assumptions. Simultaneously, data from the State Council Information Office in China suggest that more than 90% of health-care workers in Hubei province are women, emphasising the gendered nature of the health workforce and the risk that predominantly female health workers incur. 5 The closure of schools to control COVID-19 transmission in China, Hong Kong, Italy, South Korea, and beyond might have a differential effect on women, who provide most of the informal care within families, with the consequence of limiting their work and economic opportunities. Travel restrictions cause financial challenges and uncertainty for mostly female foreign domestic workers, many of whom travel in southeast Asia between the Philippines, Indonesia, Hong Kong, and Singapore. 6 Consideration is further needed of the gendered implications of quarantine, such as whether women and men's different physical, cultural, security, and sanitary needs are recognised. Experience from past outbreaks shows the importance of incorporating a gender analysis into preparedness and response efforts to improve the effectiveness of health interventions and promote gender and health equity goals. During the 2014–16 west African outbreak of Ebola virus disease, gendered norms meant that women were more likely to be infected by the virus, given their predominant roles as caregivers within families and as front-line health-care workers. 7 Women were less likely than men to have power in decision making around the outbreak, and their needs were largely unmet. 8 For example, resources for reproductive and sexual health were diverted to the emergency response, contributing to a rise in maternal mortality in a region with one of the highest rates in the world. 9 During the Zika virus outbreak, differences in power between men and women meant that women did not have autonomy over their sexual and reproductive lives, 10 which was compounded by their inadequate access to health care and insufficient financial resources to travel to hospitals for check-ups for their children, despite women doing most of the community vector control activities. 11 Given their front-line interaction with communities, it is concerning that women have not been fully incorporated into global health security surveillance, detection, and prevention mechanisms. Women's socially prescribed care roles typically place them in a prime position to identify trends at the local level that might signal the start of an outbreak and thus improve global health security. Although women should not be further burdened, particularly considering much of their labour during health crises goes underpaid or unpaid, incorporating women's voices and knowledge could be empowering and improve outbreak preparedness and response. Despite the WHO Executive Board recognising the need to include women in decision making for outbreak preparedness and response, 12 there is inadequate women's representation in national and global COVID-19 policy spaces, such as in the White House Coronavirus Task Force. 13 © 2020 Miguel Medina/Contributor/Getty Images 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. If the response to disease outbreaks such as COVID-19 is to be effective and not reproduce or perpetuate gender and health inequities, it is important that gender norms, roles, and relations that influence women's and men's differential vulnerability to infection, exposure to pathogens, and treatment received, as well as how these may differ among different groups of women and men, are considered and addressed. We call on governments and global health institutions to consider the sex and gender effects of the COVID-19 outbreak, both direct and indirect, and conduct an analysis of the gendered impacts of the multiple outbreaks, incorporating the voices of women on the front line of the response to COVID-19 and of those most affected by the disease within preparedness and response policies or practices going forward.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas

              Stigma is a well-documented barrier to health seeking behavior, engagement in care and adherence to treatment across a range of health conditions globally. In order to halt the stigmatization process and mitigate the harmful consequences of health-related stigma (i.e. stigma associated with health conditions), it is critical to have an explicit theoretical framework to guide intervention development, measurement, research, and policy. Existing stigma frameworks typically focus on one health condition in isolation and often concentrate on the psychological pathways occurring among individuals. This tendency has encouraged a siloed approach to research on health-related stigmas, focusing on individuals, impeding both comparisons across stigmatized conditions and research on innovations to reduce health-related stigma and improve health outcomes. We propose the Health Stigma and Discrimination Framework, which is a global, crosscutting framework based on theory, research, and practice, and demonstrate its application to a range of health conditions, including leprosy, epilepsy, mental health, cancer, HIV, and obesity/overweight. We also discuss how stigma related to race, gender, sexual orientation, class, and occupation intersects with health-related stigmas, and examine how the framework can be used to enhance research, programming, and policy efforts. Research and interventions inspired by a common framework will enable the field to identify similarities and differences in stigma processes across diseases and will amplify our collective ability to respond effectively and at-scale to a major driver of poor health outcomes globally.
                Bookmark

                Author and article information

                Contributors
                carmen.logie@utoronto.ca
                Journal
                J Int AIDS Soc
                J Int AIDS Soc
                10.1002/(ISSN)1758-2652
                JIA2
                Journal of the International AIDS Society
                John Wiley and Sons Inc. (Hoboken )
                1758-2652
                04 May 2020
                May 2020
                : 23
                : 5 ( doiID: 10.1002/jia2.v23.5 )
                : e25504
                Affiliations
                [ 1 ] Factor‐Inwentash Faculty of Social Work University of Toronto Toronto Canada
                Author notes
                [*] [* ] Corresponding Author: Carmen H Logie, Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street, Toronto, ON, M5S 1V4, Canada. Tel: 1(416) 946 3365. ( carmen.logie@ 123456utoronto.ca )

                Author information
                https://orcid.org/0000-0002-8035-433X
                Article
                JIA225504
                10.1002/jia2.25504
                7197953
                32365283
                375c1f5d-f257-437e-9b25-d9a46b4332be
                © 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 March 2020
                : 17 April 2020
                Page count
                Figures: 0, Tables: 0, Pages: 3, Words: 1990
                Categories
                Viewpoint
                Viewpoints
                Custom metadata
                2.0
                May 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.1 mode:remove_FC converted:04.05.2020

                Infectious disease & Microbiology
                covid‐19,stigma,hiv,gender,community,history
                Infectious disease & Microbiology
                covid‐19, stigma, hiv, gender, community, history

                Comments

                Comment on this article